RBO & Co’s Pfizer PFE Stock Holding History

RBO & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$818K	Hold	33,953	–	–	0.13%	41
2026 Q1	$953K	Buy	33,953 +4,353	+15%	+$116K	0.15%	42
2025 Q4	$737K	Hold	29,600	–	–	0.12%	43
2025 Q3	$754K	Hold	29,600	–	–	0.12%	42
2025 Q2	$718K	Hold	29,600	–	–	0.12%	42
2025 Q1	$750K	Buy	+29,600	New	+$775K	0.12%	41
2023 Q2	–	Sell	-7,400	Closed	-$302K	–	56
2023 Q1	$302K	Hold	7,400	–	–	0.05%	49
2022 Q4	$379K	Hold	7,400	–	–	0.07%	46
2022 Q3	$324K	Hold	7,400	–	–	0.06%	48
2022 Q2	$388K	Sell	7,400 -300	-4%	-$15.3K	0.07%	48
2022 Q1	$399K	Hold	7,700	–	–	0.07%	52
2021 Q4	$455K	Sell	7,700 -830	-10%	-$41.1K	0.07%	52
2021 Q3	$367K	Hold	8,530	–	–	0.06%	52
2021 Q2	$334K	Hold	8,530	–	–	0.06%	54
2021 Q1	$309K	Hold	8,530	–	–	0.06%	53
2020 Q4	$314K	Sell	8,530 -461	-5%	-$16.9K	0.06%	46
2020 Q3	$313K	Buy	+8,991	New	+$315K	0.07%	46

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RBO & Co's PFE Position: Q2 2026 in Review

RBO & Co held its Pfizer (PFE) position steady in Q2 2026 at 33,953 shares worth $818K. The position accounts for 0.13% of the portfolio, ranked #41.

RBO & Co first reported a position in PFE in Q3 2020 and has held it in 17 quarters since. The position peaked at $953K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

RBO & Co held 33,953 shares of Pfizer worth $818K as of Q2 2026.
RBO & Co left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.13% of RBO & Co's portfolio in Q2 2026, its #41 holding.
RBO & Co first reported a position in Pfizer in Q3 2020 and has held it in 17 quarters since.
RBO & Co's Pfizer position peaked at $953K in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on RBO & Co's 13F filing for Q2 2026, filed 13 Aug 2026.